L Squared Capital Partners has announced a definitive agreement for the sale of Raptor Scientific to TransDigm Group Incorporated for $655 million in cash. Founded in 2019 by L Squared, Raptor Scientific has grown into a leading provider of complex test and measurement solutions for the Defense, Space, and Aerospace markets. The company saw its revenue increase from about $9 million to approximately $90 million under L Squared’s ownership. This performance was bolstered by strategic investments in go-to-market strategies, human capital, and product development. The transaction, subject to customary closing conditions and regulatory approvals, marks L Squared’s ninth overall exit since its formation in 2014 and its second in the last 45 days. Raptor Scientific has benefited from advanced technologies and a world-class management team, aiming to support national security assets. With this acquisition, TransDigm is well-positioned to provide Raptor Scientific the scale necessary to drive future growth. The deal highlights L Squared’s focus on long-term value creation and success in the Aerospace and Defense test & measurement market. Harris Williams & Co., Vedder Price P.C., PwC, and CSP Associates advised on the transaction.

Private Equity, Aerospace & Defense, Mergers & Acquisitions,United States

L Squared Capital Partners Announces Pending Sale of Raptor Scientific to TransDigm Group Incorporated for $655 Million